Caris Life Sciences Inc. (CAI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
31.78
2.07 (6.97%)
At close: Oct 03, 2025, 3:59 PM
31.74
-0.13%
After-hours: Oct 03, 2025, 07:51 PM EDT

Caris Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
63.95M 56.4M 107.19M
Short-Term Investments
2.2M 65.18M 302.43M
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
5.89M 3.43M 43.98M
Receivables
88.24M 55.3M 40.23M
Inventory
39.57M 49M 46.96M
Other Current Assets
8.2M 4.96M 5.88M
Total Current Assets
215.73M 242.61M 516.04M
Property-Plant & Equipment
102.77M 147.51M 138.05M
Goodwill & Intangibles
19.34M 19.34M 19.34M
Total Long-Term Assets
128M 170.29M 201.38M
Total Assets
343.73M 412.9M 717.42M
Account Payables
27.79M 26.68M 27.27M
Deferred Revenue
7.47M 5.68M 1.43M
Short-Term Debt
60M 167K 52.79M
Other Current Liabilities
30.69M 22.13M 22.65M
Total Current Liabilities
165.42M 95.14M 136.91M
Long-Term Debt
319.19M 166.11M 169.57M
Other Long-Term Liabilities
2.32B 2.25B 2.07B
Total Long-Term Liabilities
2.68B 2.46B 2.28B
Total Liabilities
2.84B 2.56B 2.42B
Total Debt
424.26M 217.27M 270.87M
Book Value
-2.5B -2.14B -1.7B
Book Value Per Share
-9.81 -8.42 -6.68
Common Stock
38K 38K 138K
Retained Earnings
-2.47B -2.12B -1.68B
Comprehensive Income
210K 218K 1.7M
Shareholders Equity
-2.5B -2.14B -1.7B
Total Investments
2.2M 65.18M 302.43M